Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Long-Term Investments (2018 - 2025)

Mesoblast (MESO) posted Long-Term Investments of $1.6 million for Q4 2025, up 11.74% sequentially from $1.4 million in Q2 2025, and up 28.39% YoY from $1.2 million in Q4 2024.

Analysis

Mesoblast (MESO) Long-Term Investments (2018 - 2025) Analysis & Trends

Mesoblast has reported Long-Term Investments for 9 years, with the latest figure at $1.6 million in Q4 2025.

  • Quarterly Long-Term Investments rose 28.39% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 28.39% YoY) and the FY2025 annual result came in at $1.4 million, up 36.88% from the prior year.
  • Long-Term Investments advanced to $1.6 million in Q4 2025 per MESO's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $2.3 million in Q4 2021 and troughed at $826000.0 in Q4 2023.
  • A 5-year average of $1.7 million and a median of $1.8 million in 2022 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2023 and 2024: Long-Term Investments tumbled 57.62% in 2023, then soared 46.25% in 2024.
  • Over 5 years, Long-Term Investments stood at $2.3 million in 2021, then dropped by 16.96% to $1.9 million in 2022, then sank by 57.62% to $826000.0 in 2023, then soared by 46.25% to $1.2 million in 2024, then advanced by 28.39% to $1.6 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $1.6 million, $1.4 million, and $1.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Mesoblast 2.24 Bn 2.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.55 Mn
Jun 30, 2025 1.39 Mn
Dec 31, 2024 1.21 Mn
Jun 30, 2024 1.01 Mn
Dec 31, 2023 826,000.00
Jun 30, 2023 1.76 Mn
Mar 31, 2023 2.03 Mn
Dec 31, 2022 1.95 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 1.76 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 2.35 Mn
Sep 30, 2021 2.23 Mn
Jun 30, 2021 2.08 Mn
Mar 31, 2021 1.98 Mn
Dec 31, 2020 1.90 Mn
Sep 30, 2020 1.95 Mn
Jun 30, 2020 1.87 Mn
Mar 31, 2020 1.77 Mn
Dec 31, 2019 1.67 Mn